# Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)

> **NCT06032572** · NA · UNKNOWN · sponsor: **Shenzhen Raysight Intelligent Medical Technology Co., Ltd.** · enrollment: 204 (estimated)

## Conditions studied

- Coronary Artery Disease
- Cardiovascular Diseases
- Coronary Disease
- Myocardial Ischemia
- Arteriosclerosis
- Vascular Disease Occlusive

## Interventions

- **PROCEDURE:** VRS100 robotic-assisted PCI
- **PROCEDURE:** Manual PCI

## Key facts

- **NCT ID:** NCT06032572
- **Lead sponsor:** Shenzhen Raysight Intelligent Medical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-08
- **Primary completion:** 2024-08-01
- **Final completion:** 2024-08-01
- **Target enrollment:** 204 (ESTIMATED)
- **Last updated:** 2023-09-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06032572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06032572, "Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06032572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*